scholarly journals P.0431 SARS-CoV-2 neuropsychiatric pathogenic mechanisms – a case report of delirium with psychotic symptoms as sole manifestation in SARS-CoV-2 positive patient

2021 ◽  
Vol 53 ◽  
pp. S313-S314
Author(s):  
I. Faria ◽  
M. Carneiro ◽  
S. Carla
Author(s):  
Gorkem Ugurlu ◽  
Mustafa Ugurlu ◽  
Meltem Kilic ◽  
Zuhal Apaydin ◽  
Ali Caykoylu

2021 ◽  
Vol 79 ◽  
pp. 164-168 ◽  
Author(s):  
Courtney Brooke Shires ◽  
Theodore Klug ◽  
Stephen Dryden ◽  
Joshua Ford

2020 ◽  
Vol 33 (03) ◽  
pp. 241-243
Author(s):  
Rajesh Kovilacar ◽  
Pankhuri Misra

Abstract Introduction The outbreak of coronavirus disease 2019 (COVID-19) has been declared as public health emergency of international concern. India is also facing this crisis with increasing number of patients being reported day by day. Here, we present a case report of COVID-19-positive patient treated with homoeopathy. Case Profile A 60-year-old female patient with fever for 4 days, cough and difficulty in breathing, headache, sore throat, loose stools and frequent urination with burning and generalised weakness for 7 days was considered for treatment in the present study. Based on the symptomatology, Arsenicum album 30 and Bryonia alba 30 were prescribed to her. Conclusion A patient of COVID-19 was successfully treated by homoeopathic medicines based on symptom similarity. Individualised homoeopathic intervention with precautionary measures can be an answer to the ongoing crisis.


2016 ◽  
Vol 64 (1) ◽  
pp. 79-82
Author(s):  
Maria Carolina de Lima Jacy MONTEIRO ◽  
Cristiane FURUSE ◽  
Larissa Cunha CÊ ◽  
Alexandre Freitas SANTANA ◽  
Vera Cavalcanti de ARAÚJO

ABSTRACT Verruciform xanthoma is a rare, benign lesion, with a papillary aspect, asymptomatic, sessile, white colored, and well-demarcated, that occurs in the gingiva and alveolar mucosa. The histopathological aspect is characterized by the presence of macrophages with foam cytoplasm (xanthoma cells) confined to the soft papillary tissue. The etiology and pathogenic mechanisms are unknown, although some hypothesis, such as local trauma or viral origin have been suggested. The aim of this article was report a clinical case of verruciform xanthoma located in the gingiva showing the clinical and histopathological aspects.


2006 ◽  
Vol 10 (1) ◽  
pp. 55-58 ◽  
Author(s):  
Eduardo José Bellotto Monteiro ◽  
Daiane Caron ◽  
Carlos Alberto Balda ◽  
Marcello Franco ◽  
Aparecido Bernardo Pereira ◽  
...  

2015 ◽  
Vol 84 (S1) ◽  
pp. 6-8
Author(s):  
Michael Blaszak ◽  
Danica Brister ◽  
Jordon Charlebois ◽  
Erica Hoe ◽  
Maggie Siu

We report on a unique clinical case of psychosis precipitated by Attention Deficit Hyperactivity Disorder (ADHD) and explore its implications for clinical practice as well as our understanding of these conditions. We describe a clinical case of a 46-year-old male presenting with auditory, olfactory, tactile, and visual hallucinations. We reviewed the literature on reported cases in which psychotic symptoms were treated with stimulant medications for ADHD comorbidity. This case report reveals the potential for properly selected patients to benefit from a consideration of ADHD comorbidity and a trial of treatment with that focus. In addition, the literature reveals a pathophysiologic association between psychosis and ADHD supported by neurobiological data. However, far more research is required to fully understand these conditions and their relationship. We conclude that ADHD and psychosis have some related pathophysiologic mechanisms but their connection has not been adequately explored. This case adds support to literature suggesting that in refractory psychosis, clinicians should re-evaluate the diagnosis and one of the considerations should be ADHD. In certain cases, the presence of psychotic symptoms with ADHD should not exclude the use of stimulants.


BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S115-S115
Author(s):  
Ciara Clarke ◽  
Clodagh Rushe ◽  
Fintan Byrne

ObjectiveWe report a case of a 58-year-old gentleman who was hospitalised intermittently for one year due to treatment resistant schizophrenia. Prior to hospitalisation he had been prescribed standard antipsychotics for decades without full resolution of positive psychotic symptoms. During his final admission lasting six months he was guarded, suspicious, irritable, constantly paced the corridor and displayed thought block and paranoid persecutory delusions. He would not enter the assessment room or allow any blood or ECG monitoring, however, he was compliant with oral medication. He was successfully treated with high dose olanzapine (40mg/day) and was discharged to the community. The aim of this study is to bring awareness and add to the body of evidence for the use of high-dose olanzapine in patients with treatment resistant schizophrenia in whom a trial of clozapine is not possible.Case reportThe patient gave written consent for this case report to be written and presented. An extensive literature review was performed and key papers were identified. Discussion focuses on the key areas in the literature.DiscussionThis case demonstrates that high-dose olanzapine can be used effectively as an alternative to clozapine in treatment resistant schizophrenia.ConclusionThis case highlights the need for further evaluation of high-dose olanzapine as an alternative to clozapine in patients with treatment-resistant schizophrenia.


2020 ◽  
Author(s):  
Hiroko Sugawara ◽  
Junpei Takamatsu ◽  
Mamoru Hashimoto ◽  
Manabu Ikeda

Abstract Background: Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agitation, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electroconvulsive therapy (ECT) are safe and effective standard treatments for catatonia; however, alternative treatment strategies have not been established in cases where these treatments are either ineffective or unavailable. Here, we report a case of catatonia associated with late paraphrenia classified as very-late-onset schizophrenia-like psychosis, which was successfully treated with lithium. Case presentation: A 66-year-old single man with hearing impairment developed hallucination and delusions and presented with catatonic stupor after a fall. He initially responded to benzodiazepine therapy; however, his psychotic symptoms became clinically evident and benzodiazepine provided limited efficacy. Blonanserin was ineffective, and ECT was unavailable. His catatonic and psychotic symptoms were finally relieved by lithium monotherapy.Conclusions: Catatonic symptoms are common in patients with mood disorders, suggesting that lithium may be effective in these cases. Moreover, lithium may be effective for both catatonic and psychotic symptoms, as it normalizes imbalances of excitatory and inhibitory systems in the brain, which underlies major psychosis. Cumulative evidence from further cases is needed to validate our findings.


Sign in / Sign up

Export Citation Format

Share Document